Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Ethnopharmacol ; 268: 113562, 2021 Mar 25.
Artigo em Inglês | MEDLINE | ID: mdl-33217519

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Shen-Fu Decoction (SFD), a classic Traditional Chinese paired herb formulation, has been widely used for the treatment of sepsis in China. This study was carried out to assess the effects of SFD in sepsis-induced intestinal permeability and intestinal epithelial tight junction damage in rats with sepsis. MATERIALS AND METHODS: A rat model of sepsis was created by cecal ligation and puncture (CLP). Rats in Sham and CLP + vehicle groups received equal distilled water, while rats in SFD group were treated by gavage of SFD (3 mg/kg, twice a day) for 72h. Mortality, sepsis-induced peritoneal inflammation, intestinal and liver histopathology damage, intestinal permeability (serum FITC-dextran and D-lactate), serum LPS, serum inflammation (PCT, TNF-α, and IL-6), and liver function (AST and ALT) were evaluated. The levels of zonula occluden (ZO-1), Occludin, Claudin-1 were analyzed by Real-time quantitative PCR and Western blotting (WB) respectively. Vasodilator-stimulated phosphoprotein (VASP) and p-VASP in intestinal epithelium were analyzed by WB. RESULTS: Our study showed that SFD markedly reduced the mortality rate of CLP rats, prevented intestine and liver damage, relieved sepsis-induced intestinal permeability and inflammation elevation, ameliorated sepsis-induced impaired intestinal permeability by regulating the expression of ZO-1, Occludin, Claudin-1 and p-VASP. CONCLUSIONS: The herbal formula SFD may be useful for reducing sepsis-induced organic damage and mortality by ameliorating the condition of sepsis-induced intestinal permeability by regulating tight junction proteins and p-VASP.


Assuntos
Moléculas de Adesão Celular/biossíntese , Medicamentos de Ervas Chinesas/uso terapêutico , Mucosa Intestinal/efeitos dos fármacos , Proteínas dos Microfilamentos/biossíntese , Fosfoproteínas/biossíntese , Sepse/tratamento farmacológico , Proteínas de Junções Íntimas/biossíntese , Animais , Moléculas de Adesão Celular/antagonistas & inibidores , Medicamentos de Ervas Chinesas/farmacologia , Expressão Gênica , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patologia , Masculino , Proteínas dos Microfilamentos/antagonistas & inibidores , Permeabilidade/efeitos dos fármacos , Fosfoproteínas/antagonistas & inibidores , Ratos , Ratos Sprague-Dawley , Sepse/metabolismo , Sepse/patologia , Proteínas de Junções Íntimas/antagonistas & inibidores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA